Publication

Byline

Location

US Patent Issued to R L FINECHEM on Sept. 29 for "Method for preparation of 1-(2-((2,4-dimethylphenyl)thio)phenyl) piperazine and its salts" (Indian Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,220, issued on Sept. 29, was assigned to R L FINECHEM PRIVATE Ltd. (Bangalore, India). "Method for preparation of 1-(2-((2,4-dimethylpheny... और पढ़ें


US Patent Issued to Emory Univeristy, Neurop on Sept. 29 for "GluN2B-subunit selective antagonists of the N-methyl-D-aspartate receptors with enhanced potency at acidic pH" (Georgia Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,221, issued on Sept. 29, was assigned to Emory Univeristy (Atlanta) and Neurop Inc. (Atlanta). "GluN2B-subunit selective antagonists of th... और पढ़ें


US Patent Issued to Ramot at Tel-Aviv University, The Board of Trustees of the Leland Stanford Junior University on Sept. 29 for "Chemiluminescence probes for tuberculosis" (Israeli, American Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,222, issued on Sept. 29, was assigned to Ramot at Tel-Aviv University Ltd. (Tel Aviv, Israel) and The Board of Trustees of the Leland Stanf... और पढ़ें


US Patent Issued to AstraZeneca on Sept. 29 for "N-(2-(3-cyano-2-azabicyclo[3.1.0hexan-2-yl)-2-oxoethyl)quinoline-4-carboxamides" (Swedish Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,223, issued on Sept. 29, was assigned to AstraZeneca AB (Sodertalje, Sweden). "N-(2-(3-cyano-2-azabicyclo[3.1.0hexan-2-yl)-2-oxoethyl)quin... और पढ़ें


US Patent Issued to PHILOCHEM on Sept. 29 for "Fibroblast activation protein ligands for targeted delivery applications" (Swiss Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,224, issued on Sept. 29, was assigned to PHILOCHEM AG (Otelfingen, Switzerland). "Fibroblast activation protein ligands for targeted deliv... और पढ़ें


US Patent Issued to The United States of America, as represented by the Secretary, Department of Health and Human Services on Sept. 29 for "LZK-targeting degraders and methods of use" (Maryland Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,225, issued on Sept. 29, was assigned to The United States of America, as represented by the Secretary, Department of Health and Human Serv... और पढ़ें


US Patent Issued to Rigel Pharmaceuticals on Sept. 29 for "Method of preparing Pralsetinib" (Dutch, American Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,226, issued on Sept. 29, was assigned to Rigel Pharmaceuticals Inc. (South San Francisco, Calif.). "Method of preparing Pralsetinib" was i... और पढ़ें


US Patent Issued to OHIO STATE INNOVATION FOUNDATION;, THE BRIGHAM AND WOMEN'S HOSPITAL on Sept. 29 for "EAAT2 activators and methods of using thereof" (Massachusetts, Ohio Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,227, issued on Sept. 29, was assigned to OHIO STATE INNOVATION FOUNDATION; (Columbus, Ohio) and THE BRIGHAM AND WOMEN'S HOSPITAL INC. (Bost... और पढ़ें


US Patent Issued to DANA-FARBER CANCER INSTITUTE on Sept. 29 for "Potent and selective inhibitors of IRAK4" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,228, issued on Sept. 29, was assigned to DANA-FARBER CANCER INSTITUTE INC. (Boston). "Potent and selective inhibitors of IRAK4" was invent... और पढ़ें


US Patent Issued to Purdue Research Foundation on Sept. 29 for "Pyrazolyl pyrimidinone compounds and the uses thereof" (Indiana, Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,229, issued on Sept. 29, was assigned to Purdue Research Foundation (West Lafayette, Ind.). "Pyrazolyl pyrimidinone compounds and the uses... और पढ़ें